logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
15/05/2025
Truist Securities: Maintains rating on Allogene Therapeutics (ALLO.US) from Buy to Buy rating, with target price adjusted from $14.00 to $10.00.
Latest
2 m ago
Small and micro caps are strong in style, and related funds are sounding the purchase limit warning.
2 m ago
Sino-U.S. reciprocal tariff reduction implemented; concentrated orders will be replenished and ports will face peak period.
5 m ago
Actively seize market opportunities, new funds boldly establish positions.
5 m ago
Favorable factors resonate to increase market attention, multiple consumer-targeted stocks are recommended for buy-in.
6 m ago
Shenzhens industrial chain advantages promote the acceleration of the development of intelligent transportation.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.